TR200200347T2 - 1,4-İkameli 4,4-diaril sikloheksanlar. - Google Patents

1,4-İkameli 4,4-diaril sikloheksanlar.

Info

Publication number
TR200200347T2
TR200200347T2 TR2002/00347T TR200200347T TR200200347T2 TR 200200347 T2 TR200200347 T2 TR 200200347T2 TR 2002/00347 T TR2002/00347 T TR 2002/00347T TR 200200347 T TR200200347 T TR 200200347T TR 200200347 T2 TR200200347 T2 TR 200200347T2
Authority
TR
Turkey
Prior art keywords
cyclohexanes
diaryl
substituted
bulus
amine
Prior art date
Application number
TR2002/00347T
Other languages
English (en)
Inventor
Siegfried B. Christensen, Iv
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200200347T2 publication Critical patent/TR200200347T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

Bulus Z'nin bir amin, alkol veya türevi oldugu Formül (I) bilesimleriyle ve keton analogu ile ilgilidir.
TR2002/00347T 1999-08-10 2000-08-10 1,4-İkameli 4,4-diaril sikloheksanlar. TR200200347T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14803499P 1999-08-10 1999-08-10

Publications (1)

Publication Number Publication Date
TR200200347T2 true TR200200347T2 (tr) 2002-06-21

Family

ID=22523946

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00347T TR200200347T2 (tr) 1999-08-10 2000-08-10 1,4-İkameli 4,4-diaril sikloheksanlar.

Country Status (19)

Country Link
US (1) US6518306B1 (tr)
EP (1) EP1202955A4 (tr)
JP (1) JP2003522129A (tr)
KR (1) KR20020022102A (tr)
CN (1) CN1368952A (tr)
AU (1) AU6763900A (tr)
BR (1) BR0013230A (tr)
CA (1) CA2378990A1 (tr)
CO (1) CO5190716A1 (tr)
CZ (1) CZ2002460A3 (tr)
HU (1) HUP0202936A3 (tr)
IL (1) IL148032A0 (tr)
MX (1) MXPA02001471A (tr)
NO (1) NO20020597L (tr)
NZ (1) NZ516620A (tr)
PL (1) PL353360A1 (tr)
TR (1) TR200200347T2 (tr)
WO (1) WO2001010385A2 (tr)
ZA (1) ZA200201036B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002088079A2 (en) * 2001-05-01 2002-11-07 Bristol-Myers Squibb Company Dual inhibitors of pde 7 and pde 4
US20040001895A1 (en) * 2002-06-17 2004-01-01 Pfizer Inc. Combination treatment for depression and anxiety
UA83266C2 (en) * 2003-12-08 2008-06-25 Уайет Oxazole derivatives of tetracyclines
ES2317223T3 (es) * 2004-04-08 2009-04-16 Wyeth Derivados de tioamida como moduladores del receptor de progesterona.
BRPI0509159B1 (pt) * 2004-04-08 2014-08-26 Wyeth Llc Processo para preparar um composto de fenoxicicloalquila
US7825265B2 (en) 2004-05-04 2010-11-02 Acadia Pharmaceuticals Inc. Compounds with activity at estrogen receptors
CN1997618A (zh) * 2004-05-04 2007-07-11 阿卡迪亚医药公司 对雌激素受体具有活性的化合物
KR100694873B1 (ko) * 2005-05-26 2007-03-13 주식회사 대인정밀 정수기
TW200716536A (en) * 2005-06-09 2007-05-01 Chugai Pharmaceutical Co Ltd Vitamin D compounds
AU2008311375A1 (en) * 2007-10-10 2009-04-16 Merck Sharp & Dohme Corp. Diphenyl substituted cycloalkanes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993019748A1 (en) * 1992-04-02 1993-10-14 Smithkline Beecham Corporation Compounds useful for treating inflammatory diseases and for inhibiting production of tumor necrosis factor
JP3192424B2 (ja) * 1992-04-02 2001-07-30 スミスクライン・ビーチャム・コーポレイション アレルギーまたは炎症疾患の治療用化合物
JPH07278038A (ja) * 1994-04-01 1995-10-24 Sumitomo Chem Co Ltd 多官能ビニルエーテル化合物
FI972676A7 (fi) * 1994-12-23 1997-08-19 Smithkline Beecham Corp 4,4-(disubstituoitu)sykloheksan-olimonomeerejä ja vastaavia yhdisteitä
AU708349B2 (en) * 1994-12-23 1999-08-05 Smithkline Beecham Corporation 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds
AR004471A1 (es) * 1995-05-31 1998-12-16 Smithkline Beecham Corp Compuestos de ciclohexan-1-ol-4,4-disustituidos, utiles en el tratamiento de enfermedades alergicas e inflamatorias y composiciones farmaceuticas que lascontienen
UY25338A1 (es) * 1998-01-07 2001-08-27 Smithkline Beecham Corp Método para tratar copd

Also Published As

Publication number Publication date
EP1202955A2 (en) 2002-05-08
WO2001010385A2 (en) 2001-02-15
NZ516620A (en) 2004-03-26
CA2378990A1 (en) 2001-02-15
JP2003522129A (ja) 2003-07-22
EP1202955A4 (en) 2004-02-11
PL353360A1 (en) 2003-11-17
MXPA02001471A (es) 2002-07-02
BR0013230A (pt) 2002-04-23
CZ2002460A3 (cs) 2002-06-12
HUP0202936A3 (en) 2003-11-28
US6518306B1 (en) 2003-02-11
NO20020597L (no) 2002-04-03
AU6763900A (en) 2001-03-05
WO2001010385A3 (en) 2001-08-16
ZA200201036B (en) 2003-04-30
HUP0202936A2 (hu) 2002-12-28
NO20020597D0 (no) 2002-02-06
CN1368952A (zh) 2002-09-11
KR20020022102A (ko) 2002-03-23
IL148032A0 (en) 2002-09-12
CO5190716A1 (es) 2002-08-29

Similar Documents

Publication Publication Date Title
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
DE69910831D1 (de) Epothilonderivate und ihre verwendung als antitumormittel
EA200200374A1 (ru) Производные хинолилпропилпиперидина, их получение и содержащие их композиции
TR200401755T4 (tr) Metanesulfonamıdo-benzofuran hazırlama metodu ve bunun sentez ara ürünü olarak kullanım şekli
BR0316609A (pt) Sinomenina e compostos de sinomenina, sìntese e uso
TR200201072T2 (tr) 4-Triflorometilsulfinilpirazol türevi hazırlama süreci
MXPA02011370A (es) Iminoazinas substituidas.
ATE231859T1 (de) Tetrahydrothiopyran-phenyloxazolidinon-s-oxide
TR200200347T2 (tr) 1,4-İkameli 4,4-diaril sikloheksanlar.
TR200302288T2 (tr) Terapi için yeni bileşikler ve metotlar.
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
AR031941A1 (es) Proceso para la preparacion de derivados de fenetilamina
DK1204659T3 (da) Serotonerge benzofuraner
DE60228429D1 (de) Medizinische zusammensetzung, die ein 1,3-thiazinderivat enthält
ATE227265T1 (de) Äther; ihre verwendung als riech- und geschmackstoffe; ihre herstellung
EP0605728A4 (en) Chromone derivative and aldose reductase inhibitor containing the same as active ingredient.
BR0010488A (pt) Tienocicloalqu(en)ilamino-1,3,5-triazinas substituìdas
NO20000469L (no) Legemiddel for skallethet og andre sykdommer
ATE218138T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
NO994107D0 (no) Preparater for behandling eller forhindring av prostatakreft
DE602004004093D1 (de) Alkylierte iminodibenzyle als antioxidationsmittel
TR199801839T2 (tr)
DE60315081D1 (de) Antiozonant funktionalisierte benzotriazole uv absorber und ihre herstellungsverfahren
ATE340175T1 (de) Imidazo(4,5-böchinolinderivate und ihre verwendung als inhibitoren der induzierbaren no- synthase
TR199902097A2 (tr) Mikrobial transformasyon.